Search clinical trials for: DWJ1351(FDC Amlodipine/Olmesartan/Rosuvastatin)

Total 104 results

Daewoong Pharmaceutical Co. LTD.

Completed

Clinical Trial to Investigate the Efficacy and Safety of DWJ1351

Healthy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemias

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Unknown

Study of DWJ1351 in Healthy Male Volunteers

Healthy
Daewoong Pharmaceutical Co. LTD.

Unknown

Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

Hypertension, Dyslipidemia

Korea, Republic of
Daiichi Sankyo, Inc.

Completed

Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

Essential Hypertension

Italy, Poland, Ukraine, Germany, Spain, Bulgaria, Romania, Denmark, Belgium, Netherlands, Russian Federation, Hungary, Slovakia, Czechia, Latvia
Samsung Medical Center

Unknown

The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease

Coronary Syndrome

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Recruiting

Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

Hypertension | Dyslipidemias

Korea, Republic of
Daiichi Sankyo, Inc.

Completed

Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension

Essential Hypertension

France, Poland, Ukraine, Belgium, Germany, Spain, Bulgaria, Romania, Denmark, Russian Federation, Netherlands, Austria, Slovakia, Czechia
Daewoong Pharmaceutical Co. LTD.

Enrolling by invitation

Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab

Hypertension | Dyslipidemia

Korea, Republic of
Severance Hospital

Completed

Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers

Healthy

Korea, Republic of
GlaxoSmithKline
SingHealth Investigational Medicine Unit, Singapore

Completed

Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions

Hypertension

Singapore
Daewoong Pharmaceutical Co. LTD.

Completed

Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers

Healthy

Korea, Republic of
COLM Study Research Organization
Japan Heart Foundation

Completed

Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

Hypertension | Cardiovascular Disease | Diabetes

Japan
Institut für Pharmakologie und Präventive Medizin

Completed

Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg (Sevicontrol-2)

Hypertension

Germany
Pfizer

Terminated

Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

Hypertension

Philippines
Daewoong Pharmaceutical Co. LTD.

Recruiting

Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab

Hypertension | Hyperlipidemias

Korea, Republic of
Yuhan Corporation

Completed

Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin

Hypertension | Hyperlipidemia

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Hypertension | Hyperlipidemia

Korea, Republic of
Sankyo Pharma Gmbh

Completed

Amlodipine as add-on to Olmesartan in Hypertension

Essential Hypertension

Germany
Daiichi Sankyo, Inc.

Completed

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

Hypertension

United States
Radboud University Medical Center

Not yet recruiting

Multi-Omics to Predict the Blood Pressure Response to Antihypertensives (HT-PREDICT)

Primary Hypertension
Jeil Pharmaceutical Co., Ltd.

Completed

Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

Dyslipidemia With Hypertension

Korea, Republic of
The Louis & Rachel Rudin Foundation
Daiichi Sankyo, Inc.

Completed

Renin Profiling in Selection of Initial Antihypertensive Drug

Hypertension

United States
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

Hypertension

Germany, Switzerland, United Kingdom
OSCAR Study
Japan Heart Foundation

Completed

OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study

Cardiovascular Diseases | Hypertension

Japan
Boryung Pharmaceutical Co., Ltd

Completed

Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia (FIRST)

Dyslipidemia | Essential Hypertension

Korea, Republic of
Sankyo Pharma Gmbh

Completed

Olmesartan as an add-on to Amlodipine in Hypertension

Essential Hypertension

Germany
Wilhelminenspital Vienna
Association for the Promotion of Research in Atherosclerosis, Thrombosis... and other collaborators

Completed

Lowering Blood Pressure in Primary Care in Vienna (Low BP Vienna)

Hypertension

Austria
Novartis

Completed

Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

Hypertension

Germany
Daiichi Sankyo, Inc.

Completed

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Hypertension | Type 2 Diabetes

United States
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome (VAMOS)

Hypertension | Metabolic Syndrome

Germany
Yonsei University

Completed

Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

Hypertension | Dyslipidemias

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

Hypertension | Dyslipidemia

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

Hypertension | Hyperlipidemia

Korea, Republic of
Yuhan Corporation

Terminated

PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

Hypertension | Hyperlipidemia

Korea, Republic of
Monash University
Schering-Plough

Withdrawn

Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study (ACCESS)

Hypertension

Australia
Daiichi Sankyo, Inc.
Integrium

Completed

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure (BP CRUSH)

Hypertension

United States
Sankyo Pharma Gmbh

Completed

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension (OLMETREAT)

Essential Hypertension

France, Austria, Switzerland, Belgium, Germany, Italy, Netherlands, United Kingdom, Portugal
Daiichi Sankyo, Inc.

Completed

Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension (Benibest)

Essential Hypertension
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.

Healthy Subjects
EMS

Not yet recruiting

Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control

Arterial Hypertension
Institut für Pharmakologie und Präventive Medizin

Completed

Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine (Sevicontrol1)

Hypertension

Germany
GlaxoSmithKline

Completed

Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions

Hypertension

South Africa
EMS

Not yet recruiting

Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

Essential Arterial Hypertension
Yuhan Corporation

Completed

Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
InVasc Therapeutics, Inc.

Unknown

Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome (AMORE)

Hypertension

United States
Daiichi Sankyo, Inc.

Completed

Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension

Hypertension

United States
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

Hypertension

Spain
Sang Hyun Ihm, MD PhD
Daiichi Sankyo Korea Co., Ltd.; Daewoong Pharmaceutical Co. LTD.

Completed

Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM (EARTH)

Hypertension

Korea, Republic of
Boehringer Ingelheim

Completed

Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use

Healthy

Japan

3

Subscribe